What You Should Know: – G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific…
Continue Reading
Caris Life Sciences Logo
What You Should Know:
– Caris Life Sciences (Caris), a leader in AI-powered precision medicine, and COTA, Inc., a real-world data (RWD) and analytics expert, announced a strategic collaboration today.
– The strategic…
Continue Reading
What You Should Know:
– Genomics plc, a leader in polygenic risk score (PRS) technology, and pharmaceutical giant GSK inks a new collaboration to explore the potential of PRS for optimizing clinical trial design.
– The…
Continue Reading
What You Should Know:
– G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, and Pepper Bio, the world’s first transomics drug discovery and development company, announced a global licensing agreement (excluding the Asia-Pacific region)…
Continue Reading
What You Should Know:
– John Snow Labs, the AI for healthcare company announced the findings of the inaugural Generative AI in Healthcare Survey. Conducted by Gradient Flow, the research explores the trends, tools, and…
Continue Reading
The new EU AI Act will have global reach – and a big impact on the medtech and life sciences sector. By Sharon Lamb, Deniz Tschammler and Lorraine Maisnier-Boché from international law firm McDermott…
Continue Reading
What You Should Know:
– Deciphex, a leading digital pathology company based in Dublin, Ireland, has announced a collaborative effort with Novartis, a prominent multinational pharmaceutical corporation.
– The strategic partnership focuses on developing innovative artificial…
Continue Reading
What You Should Know:
– COTA, a leading real-world data (RWD) and analytics company in oncology, has announced a new collaboration with Sanofi.
– The strategic partnership aims to leverage RWD and artificial intelligence (AI) to…
Continue Reading
What You Should Know:
– When developing new drugs, nutritional products, or pesticides, it’s critical that unknown molecules are identified correctly. But accurate identification is a lengthy process and all too often unsuccessful, leading to…
Continue Reading
Dr. Jayawant Fuke, Senior Director of Lifecycle Safety, IQVI Hye Jin Choi, R. Ph., Sr. Director of Regulatory Affairs and Drug Development Solutions, IQVIA Asia Pacific The biopharmaceutical market within the Japan and Asia-Pacific…
Continue Reading
